Chemotherapy After Surgery

Adjuvant chemotherapy is medicine given after surgery to treat cancer cells that may remain elsewhere in the body.

It is a systemic treatment, meaning the medicines travel through the bloodstream. The aim is to reduce the chance of cancer returning after the visible tumour has been removed, rather than to treat a tumour that can still be seen.

Before starting, the oncology team reviews the operation, cancer type, pathology findings, overall health and current medicines. Treatment may be given into a vein or as tablets, depending on the regimen. It is delivered in planned cycles, with rest periods that allow the body to recover.

Blood tests and symptom checks help the team decide whether each cycle can go ahead as planned or needs adjustment. Bring an up-to-date medicines list, including supplements, to every review.

Tiredness, nausea, appetite changes, mouth soreness, bowel changes, hair loss and tingling in hands or feet can occur. The pattern depends on the medicines used and can change from cycle to cycle. The team can offer medicines and practical support for many symptoms.

Contact the oncology service promptly for a fever, chills, shortness of breath, chest pain, confusion, uncontrolled vomiting or diarrhoea, unusual bleeding, or an inability to drink fluids. These symptoms can signal infection, dehydration, a clot or another problem that needs urgent assessment.

The likely benefit is individual. It depends on the cancer type, its features under the microscope, whether lymph nodes were involved, the surgery performed and a person’s health. Your clinician balances that expected benefit against side effects and the practical demands of treatment.

Finishing every planned cycle is not the only measure of good care. Dose changes, delays or a change of regimen may be appropriate when safety or day-to-day functioning requires it.

Adjuvant chemotherapy usually begins after enough healing from surgery. It may be one part of a wider plan that includes radiotherapy, hormone treatment, targeted treatment or monitoring. Keep a record of symptoms, temperatures when advised, and any medicines taken between appointments.

It may be offered after surgery for some cancers when pathology and clinical details suggest that treating possible microscopic cells could be useful. For breast cancer, the decision can include tumour features, lymph-node findings and other treatments being considered. Not everyone benefits from the same approach.

The team first confirms recovery from surgery and plans the regimen. At each cycle, staff check blood counts and symptoms before giving treatment. After the planned course, the care team reviews recovery, ongoing symptoms and the next phase of follow-up.

Energy, appetite and concentration may vary during treatment and after the final cycle. Gentle activity, regular fluids and small meals can be easier than trying to maintain a usual routine. Recovery is personal; tell the team about symptoms that interfere with sleeping, eating, work or caring responsibilities.

Chemotherapy can lower blood-cell counts and raise infection risk. Some medicines can affect nerves, the heart, kidneys, hearing or fertility, so the regimen is selected and monitored carefully. Discuss pregnancy, contraception, fertility preservation and existing heart, kidney or liver conditions before treatment begins.

Depending on the cancer and surgery results, the plan may instead use close follow-up, radiotherapy, hormone treatment, targeted treatment, immunotherapy or a different chemotherapy regimen. The appropriate choice follows a detailed discussion of the goals of care and the features of the cancer.

Cancer treatment is coordinated by an oncology team with access to infusion services, blood testing and urgent advice. Ask who to contact after hours, how prescriptions are handled and whether a nurse navigator, dietitian or pharmacist is available.